Connect with us

Hi, what are you looking for?


Pfizer, U.S. health officials to discuss COVID boosters on Monday -company

Stock Markets6 minutes ago (Jul 11, 2021 01:05PM ET)

(C) Reuters. FILE PHOTO: U.S. first lady Jill Biden looks on as Alfred Lee Smith is vaccinated with the Johnson & Johnson COVID-19 vaccination at a vaccination facility at Alfred E. Beach High School in Savannah, Georgia, U.S. July 8, 2021. Jim Watson/Pool via REUTER


WASHINGTON (Reuters) – COVID-19 vaccine maker Pfizer Inc (NYSE:PFE) will meet with federal health officials as soon as Monday to discuss the need for a booster dose of the coronavirus vaccine as it prepares to seek authorization, the company said on Sunday.

The meeting comes days after the drugmaker and its partner BioNTech SE (NASDAQ:BNTX) announced plans to seek U.S. and European regulatory approval for a third dose of their COVID-19 shot amid the spread of variants and data they said showed heightened risk of infection six months after initial inoculation.

That push prompted a quick response from the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention, saying Americans do not need a booster right now.

On Monday, Pfizer is scheduled to meet with representatives of the FDA, a company spokesperson said. The meeting was first reported by the Washington Post.

Representatives for the U.S. Department of Health and Human Services did not immediately respond to a request for comment.

Anthony Fauci, President Joe Biden’s chief medical adviser who also directs the National Institute of Allergy and Infectious Diseases, as well as the heads of the National Institutes of Health and the CDC were also among those invited to the briefing, which could move to another day, according to the Post’s report.

Fauci, in several television interviews on Sunday, said U.S. health officials were not dismissing the possible future need for boosters — especially as breakthrough infections among those who have been vaccinated have emerged — but that more data is needed for any formal recommendation.

“There’s a lot of dynamic things going on right now,” he told ABC News’ “This Week” program.

“There are studies being done now ongoing as we speak about looking at the feasibility about if and when we should be boosting people… there’s a lot of work going on to examine this in real time,” he added on CNN’s “State of the Union.”

Despite the FDA and CDC’s statement, “that doesn’t mean that we’re not very, very actively following and gathering all of this information to see if and when we might need it and if and when we do, we’ll have everything in place to do it.”

U.S. health officials are still struggling to get people in some areas to receive their initial inoculations as the highly contagious Delta variant has grown to be the nation’s dominant strain, with COVID-19 cases rising mostly among the unvaccinated.

European officials has also said vaccines currently seem protective against variants. Canada has also said it is monitoring variants and the possible need for boosters.

While some scientists have also questioned the need for booster shots, others have said they could be beneficial for the elderly and other vulnerable populations, although it is unclear when they would be needed.

Some public health experts have also expressed concern that authorizing boosters in wealthy developed nations while other countries are still struggling against initial inoculations will further exacerbate vaccine inequity.

Pfizer, U.S. health officials to discuss COVID boosters on Monday -company

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like


Stock Markets25 minutes ago (Jul 16, 2021 05:46PM ET) (C) Reuters. FILE PHOTO: Johnson & Johnson’s Neutrogena Cool Dry Sport sunscreen, which is part...


Builders, creators and developers, this one’s for you! TechCrunch has always been about discovering fresh solutions and shining the light on exciting, new products...


(C) Reuters. FILE PHOTO: Indian billionaire Gautam Adani speaks during an interview with Reuters at his office in the western Indian city of Ahmedabad...

Disclaimer: it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Wise Gazette. All Rights Reserved